D
Esperion Therapeutics, Inc. ESPR
$1.50 $0.000.00%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 114.30% 52.00% 186.33% 466.14% 71.38%
Total Other Revenue -- -- -- -- --
Total Revenue 114.30% 52.00% 186.33% 466.14% 71.38%
Cost of Revenue 25.40% -2.05% -6.28% -45.44% -21.51%
Gross Profit 963.65% 319.64% 1,609.00% 710.87% 116.63%
SG&A Expenses -18.71% 20.26% 30.11% 40.42% 88.18%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -1.45% 10.01% 13.38% -10.24% 21.66%
Operating Income 89.57% 41.79% 106.96% 248.69% 0.34%
Income Before Tax 62.16% 28.43% -24.01% 198.87% -1.54%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations 62.16% 28.43% -24.01% 198.87% -1.54%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 62.16% 28.43% -24.01% 198.87% -1.54%
EBIT 89.57% 41.79% 106.96% 248.69% 0.34%
EBITDA 89.63% 41.83% 106.98% 249.02% 0.14%
EPS Basic 78.26% 58.91% 28.24% 145.82% 33.61%
Normalized Basic EPS 79.96% 58.92% 89.90% 145.56% 33.92%
EPS Diluted 78.26% 58.91% 28.24% 142.49% 33.61%
Normalized Diluted EPS 79.96% 58.92% 89.90% 140.67% 33.92%
Average Basic Shares Outstanding 73.99% 74.25% 72.82% 115.78% 52.96%
Average Diluted Shares Outstanding 73.99% 74.25% 72.82% 141.77% 52.96%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings